Veterinary Clostridium Vaccine Market Size, Share and Global Trend By Animal (Ovine, Bovine, Equine, Porcine, Poultry, Others), By Distribution Channel (Veterinary Hospitals & Clinics, Retail Pharmacies, Online Pharmacies, Veterinary Research Institutes , Others), and Regional Forecast, 2024-2032

Clostridium vaccines are frequently administered to animals such as sheep and others for prevention of several clostridial diseases. Clostridial diseases are caused by a group of bacteria that occur widely across nature such as in soil, sewage, water, and guts of animals and the bacteria may often live in the same environment as the affected animal. The animals affected with clostridial diseases include ovine, bovine, equine, porcine, poultry amongst others. Some of the examples of clostridial diseases include tetanus, black leg, malignant edema, black disease, botulism, and pulpy kidney.

Some of the symptoms associated with clostridial diseases include sudden death with or without gut signs such as stomach pain & diarrhea, sudden death with swollen legs & heads and nervous symptoms. The factors causing clostridial diseases include changes from poor feed to good feed, lack of veterinary care following procedures such as castration, tail docking, wound treatment & cleaning, stress & animals eating contaminated bones and old carcasses. Veterinary clostridium vaccines are especially important because clostridial diseases can only be prevented by the vaccination procedure and in the late stages of the disease, it is often fatal to the animals. These trends are anticipated to lead to the positive growth of the veterinary clostridium vaccine market.

To gain extensive insights into the market, Request for Customization

The global veterinary clostridium vaccine market is anticipated to grow owing to a number of factors such as the increasing clostridial diseases, increasing incidences of infection due to clostridial diseases and the increase in livestock ownership. Other factors include the high fatality rates of clostridial diseases, increased demand for meat and animal-based products, usage of animals in agriculture, easy accessibility and affordability of treatment, increasing awareness of animal health and welfare, the increasing government initiatives and increasing animal adoption. According to the United States Department of Agriculture (USDA), the population of cattle in the U.S. in 2016, was 92 million and a sizable population was susceptible to clostridial diseases. These trends combined with the other factors are expected to positively contribute to market growth.

Certain factors such as lower accessibility in emerging nations and higher maintenance cost are expected to hamper the growth of the global veterinary clostridium vaccine market during the forecast period.

Key Players Covered:

Some of the major companies that are present in the global veterinary clostridium vaccine market are Bimeda, Inc., Virbac, Ceva, Bayer AG, Elanco, MSD Animal Health, Boehringer Ingelheim International GmbH, Zoetis Services LLC, and others.

SEGMENTATION

Among the segmentation, porcine in the animal segment is projected to hold a considerable share of the global veterinary clostridium vaccine market due to a higher prevalence of zoonotic diseases in porcine animals and the considerably increasing demand for porcine based products.

Key Insights

Regulatory Scenario for Key Countries

New Advances in Clostridium Vaccines

Recent Industry Developments such as Partnerships, Mergers, and Acquisitions

Prevalence of Clostridial Diseases by Key Countries

Overview of Meat Consumption by Key Countries

Regional Analysis:

North America dominates the global veterinary clostridium vaccine market due to a number of factors such as the rising livestock rates, increasing the prevalence of clostridial diseases, increasing consumption of meat and animal-based products, highly fatal nature of the disease, growing pool of veterinarians and a large number of hospitals & clinics. The Asia Pacific is the fastest emerging market due to large livestock animal pool, increasing incidences of clostridial diseases, increasing awareness of animal welfare and introduction of government initiatives are expected to contribute positively in the market’s growth.

Key Industry Developments

In February 2019, Merck Animal Health and Rapid Genomics signed an exclusive agreement for vaccine verification, where Merck has exclusive rights to Rapid Genomics’ vaccination verification tool, Viral Flex-Seq

In August 2016, Boehringer Ingelheim Vetmedica, Inc. launched the Alpha-7 vaccine, the only first of a kind vaccine, single dose vaccination providing a 7 way defence against clostridial diseases